Related references
Note: Only part of the references are listed.Medial frontal GABA is lower in older schizophrenia: a MEGA-PRESS with macromolecule suppression study
L. M. Rowland et al.
MOLECULAR PSYCHIATRY (2016)
Behavioral sequelae of astrocyte dysfunction: focus on animal models of schizophrenia
Meng Xia et al.
SCHIZOPHRENIA RESEARCH (2016)
Evaluation of Myo-Inositol as a Potential Biomarker for Depression in Schizophrenia
Joshua Chiappelli et al.
NEUROPSYCHOPHARMACOLOGY (2015)
In vivo assessment of neurotransmitters and modulators with magnetic resonance spectroscopy: Application to schizophrenia
S. Andrea Wijtenburg et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2015)
Glutamate as a mediating transmitter for auditory hallucinations in schizophrenia: A 1H MRS study
Kenneth Hugdahl et al.
SCHIZOPHRENIA RESEARCH (2015)
Glial cells as key players in schizophrenia pathology: recent insights and concepts of therapy
Hans-Gert Bernstein et al.
SCHIZOPHRENIA RESEARCH (2015)
Alterations in frontal white matter neurochemistry and microstructure in schizophrenia: implications for neuroinflammation
J. Chiappelli et al.
TRANSLATIONAL PSYCHIATRY (2015)
Glutamate-mediated excitotoxicity in schizophrenia: A review
Eric Plitman et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2014)
Metabolic alterations associated with schizophrenia: a critical evaluation of proton magnetic resonance spectroscopy studies
Anne Schwerk et al.
JOURNAL OF NEUROCHEMISTRY (2014)
Imaging glutamate in schizophrenia: review of findings and implications for drug discovery
E. M. P. Poels et al.
MOLECULAR PSYCHIATRY (2014)
Magnetic resonance spectroscopy investigations of functionally defined language areas in schizophrenia patients with and without auditory hallucinations
Philipp Homan et al.
NEUROIMAGE (2014)
Effects of APOE ε4, age, and HIV on glial metabolites and cognitive deficits
Linda Chang et al.
NEUROLOGY (2014)
Atypical antipsychotic drug treatment for 6 months restores N-acetylaspartate in left prefrontal cortex and left thalamus of first-episode patients with early onset schizophrenia: A magnetic resonance spectroscopy study
Jing-Li Gan et al.
PSYCHIATRY RESEARCH-NEUROIMAGING (2014)
Efficacy of Anti-inflammatory Agents to Improve Symptoms in Patients With Schizophrenia: An Update
Iris E. Sommer et al.
SCHIZOPHRENIA BULLETIN (2014)
Specific Glial Functions Contribute to Schizophrenia Susceptibility
Andrea Goudriaan et al.
SCHIZOPHRENIA BULLETIN (2014)
Glutamatergic abnormalities in schizophrenia: A review of proton MRS findings
Eline M. P. Poels et al.
SCHIZOPHRENIA RESEARCH (2014)
The Problem of Spurious Correlations Between Pairs of Brain Metabolite Values Measured in the Same Voxel With Magnetic Resonance Spectroscopy Reply
Nina V. Kraguljac et al.
JAMA PSYCHIATRY (2014)
The Problem of Spurious Correlations Between Pairs of Brain Metabolite Values Measured in the Same Voxel With Magnetic Resonance Spectroscopy
Richard Maddock
JAMA PSYCHIATRY (2014)
Increased Glutamine in Patients Undergoing Long-term Treatment for Schizophrenia A Proton Magnetic Resonance Spectroscopy Study at 3 T
Juan R. Bustillo et al.
JAMA PSYCHIATRY (2014)
Striatal glutamate and the conversion to psychosis: a prospective 1H-MRS imaging study
Camilo de la Fuente-Sandoval et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2013)
Magnetic Resonance Spectroscopy to Assess NeuroInflammation and Neuropathic Pain
Linda Chang et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2013)
Glutamate in Schizophrenia: A Focused Review and Meta-Analysis of H-1-MRS Studies
Anouk Marsman et al.
SCHIZOPHRENIA BULLETIN (2013)
In Vivo Measurements of Glutamate, GABA, and NAAG in Schizophrenia
Laura M. Rowland et al.
SCHIZOPHRENIA BULLETIN (2013)
Adjunctive Use of Nonsteroidal Anti-inflammatory Drugs for Schizophrenia: A Meta-analytic Investigation of Randomized Controlled Trials
Masahiro Nitta et al.
SCHIZOPHRENIA BULLETIN (2013)
Inflammation and Schizophrenia
Brian Kirkpatrick et al.
SCHIZOPHRENIA BULLETIN (2013)
Proton magnetic resonance spectroscopy of the substantia nigra in schizophrenia
Meredith A. Reid et al.
SCHIZOPHRENIA RESEARCH (2013)
Antipsychotics' effects on blood levels of cytokines in schizophrenia: A meta-analysis
Valerie Tourjman et al.
SCHIZOPHRENIA RESEARCH (2013)
Abnormal expression of glutamate transporters in temporal lobe areas in elderly patients with schizophrenia
Dan Shan et al.
SCHIZOPHRENIA RESEARCH (2013)
Increased Hippocampal Glutamate and Volumetric Deficits in Unmedicated Patients With Schizophrenia
Nina V. Kraguljac et al.
JAMA PSYCHIATRY (2013)
Glutamate Levels in the Associative Striatum Before and After 4 Weeks of Antipsychotic Treatment in First-Episode Psychosis A Longitudinal Proton Magnetic Resonance Spectroscopy Study
Camilo de la Fuente-Sandoval et al.
JAMA PSYCHIATRY (2013)
Elevated Prefrontal Cortex γ-Aminobutyric Acid and Glutamate-Glutamine Levels in Schizophrenia Measured In Vivo With Proton Magnetic Resonance Spectroscopy
Lawrence S. Kegeles et al.
ARCHIVES OF GENERAL PSYCHIATRY (2012)
Ketamine effects on brain GABA and glutamate levels with 1H-MRS: relationship to ketamine- induced psychopathology
J. M. Stone et al.
MOLECULAR PSYCHIATRY (2012)
Kynurenines in the mammalian brain: when physiology meets pathology
Robert Schwarcz et al.
NATURE REVIEWS NEUROSCIENCE (2012)
Regional Decoupling of N-acetyl-aspartate and Glutamate in Schizophrenia
Nina V. Kraguljac et al.
NEUROPSYCHOPHARMACOLOGY (2012)
Neurometabolites in schizophrenia and bipolar disorder - A systematic review and meta-analysis
Nina Vanessa Kraguljac et al.
PSYCHIATRY RESEARCH-NEUROIMAGING (2012)
Increased Levels of Kynurenine and Kynurenic Acid in the CSF of Patients With Schizophrenia
Klas R. Linderholm et al.
SCHIZOPHRENIA BULLETIN (2012)
Bridging the gap between the immune and glutamate hypotheses of schizophrenia and major depression: Potential role of glial NMDA receptor modulators and impaired blood-brain barrier integrity
Johann Steiner et al.
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY (2012)
Persistence of HIV-associated cognitive impairment, inflammation, and neuronal injury in era of highly active antiretroviral treatment
Jarek Harezlak et al.
AIDS (2011)
Glutamate as a Marker of Cognitive Function in Schizophrenia: A Proton Spectroscopic Imaging Study at 4 Tesla
Juan R. Bustillo et al.
BIOLOGICAL PSYCHIATRY (2011)
Proton Magnetic Resonance Spectroscopy and Illness Stage in Schizophrenia-A Systematic Review and Meta-Analysis
Stefan Brugger et al.
BIOLOGICAL PSYCHIATRY (2011)
Higher Levels of Glutamate in the Associative-Striatum of Subjects with Prodromal Symptoms of Schizophrenia and Patients with First-Episode Psychosis
Camilo de la Fuente-Sandoval et al.
NEUROPSYCHOPHARMACOLOGY (2011)
Treatment resistant schizophrenia and response to antipsychotics: A review
Takefumi Suzuki et al.
SCHIZOPHRENIA RESEARCH (2011)
Increased Synaptic Dopamine Function in Associative Regions of the Striatum in Schizophrenia
Lawrence S. Kegeles et al.
ARCHIVES OF GENERAL PSYCHIATRY (2010)
Proton MRS in twin pairs discordant for schizophrenia
E. S. Lutkenhoff et al.
MOLECULAR PSYCHIATRY (2010)
Elevated Striatal Dopamine Function Linked to Prodromal Signs of Schizophrenia
Oliver D. Howes et al.
ARCHIVES OF GENERAL PSYCHIATRY (2009)
Imaging the Glutamate System in Humans: Relevance to Drug Discovery for Schizophrenia
James M. Stone
CURRENT PHARMACEUTICAL DESIGN (2009)
Metabolite changes and gender differences in schizophrenia using 3-Tesla proton magnetic resonance spectroscopy (1H-MRS)
Shin'Ya Tayoshi et al.
SCHIZOPHRENIA RESEARCH (2009)
Inflammation and the glutamate system in schizophrenia: implications for therapeutic targets and drug development
Norbert Mueller
EXPERT OPINION ON THERAPEUTIC TARGETS (2008)
Brain region binding of the D2/3 agonist [11C]-(+)-PHNO and the D2/3 antagonist [11C]raclopride in healthy humans
Ariel Graff-Guerrero et al.
HUMAN BRAIN MAPPING (2008)
A 1H-MRS investigation of the medial temporal lobe in antipsychotic-naive and early-treated first episode psychosis
Stephen J. Wood et al.
SCHIZOPHRENIA RESEARCH (2008)
Proton magnetic resonance spectroscopy during initial treatment with antipsychotic medication in schizophrenia
Juan R. Bustillo et al.
NEUROPSYCHOPHARMACOLOGY (2008)
Brain metabolite abnormalities in the white matter of elderly schizophrenic subjects: Implication for glial dysfunction
Linda Chang et al.
BIOLOGICAL PSYCHIATRY (2007)
EAAT2 regulation and splicing: relevance to psychiatric and neurological disorders
T. L. Lauriat et al.
MOLECULAR PSYCHIATRY (2007)
How do glial-neuronal interactions fit into current neurotransmitter hypotheses of schizophrenia?
Daniel Kondziella et al.
NEUROCHEMISTRY INTERNATIONAL (2007)
Error images for spectroscopic imaging by LCModel using Cramer-Rao bounds
F Jiru et al.
MAGNETIC RESONANCE MATERIALS IN PHYSICS BIOLOGY AND MEDICINE (2006)
Assessment of glutamate and glutamine contribution to in vivo N-acetylaspartate quantification in human brain by 1H-magnetic resonance spectroscopy
V Clementi et al.
MAGNETIC RESONANCE IN MEDICINE (2005)
A review of the possible relevance of inositol and the phosphatidylinositol second messenger system (PI-cycle) to psychiatric disorders - focus on magnetic resonance spectroscopy (MRS) studies
H Kim et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2005)
Effects of ketamine on anterior cingulate glutamate metabolism in healthy humans: A 4-T proton MRS study
LM Rowland et al.
AMERICAN JOURNAL OF PSYCHIATRY (2005)
Diffusely elevated cerebral choline and creatine in relapsing-remitting multiple sclerosis
M Inglese et al.
MAGNETIC RESONANCE IN MEDICINE (2003)
Glutamate and glutamine in the anterior cingulate and thalamus of medicated patients with chronic schizophrenia and healthy comparison subjects measured with 4.0-T proton MRS
J Theberge et al.
AMERICAN JOURNAL OF PSYCHIATRY (2003)
Glutamate and glutamine measured with 4.0 T proton MRS in never-treated patients with schizophrenia and healthy volunteers
J Théberge et al.
AMERICAN JOURNAL OF PSYCHIATRY (2002)
Spectral profiles of cultured neuronal and glial cells derived from HRMAS 1H NMR spectroscopy
JL Griffin et al.
NMR IN BIOMEDICINE (2002)
Magnetic resonance spectroscopy and its applications in psychiatry
GS Malhi et al.
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY (2002)
High choline concentrations in the caudate nucleus in antipsychotic-naive patients with schizophrenia
JR Bustillo et al.
AMERICAN JOURNAL OF PSYCHIATRY (2002)
Reduced NAA in the thalamus and altered membrane and glial metabolism in schizophrenic patients detected by 1H-MRS and tissue segmentation
DP Auer et al.
SCHIZOPHRENIA RESEARCH (2001)
The emerging role of glutamate in the pathophysiology and treatment of schizophrenia
DC Goff et al.
AMERICAN JOURNAL OF PSYCHIATRY (2001)
Automatic quantitation of localized in vivo 1H spectra with LCModel
SW Provencher
NMR IN BIOMEDICINE (2001)
Magnetic resonance spectroscopy and schizophrenia: what have we learnt?
ALA Vance et al.
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY (2000)
Share Paper
